Dosage variation depends on body mass scaling factors, target purpose (soft tissue recovery focus or tendon repair focus), administration route selection (subcutaneous delivery or intramuscular delivery), and reconstitution concentration, affecting injection volume per dose
[1] [2] The age-related drop in NAD+ levels is caused by rising levels of CD38, a membrane-bound NADase that degrades both NAD+ and its precursor nicotinamide mononucleotide, according to a 2016 study in mice, which exhibit age-related declines in NAD+ levels similar to those seen in humans
Boost your body's natural healing process with Alpha Labs BPC 157 capsules
For most people, it will take a period of up to 12 weeks to see results using AOD 9604
The peptide cycle planning guide helps structure timing and transitions
The emerging research on MOTS-c as another mitochondrial peptide adds additional options for researchers designing energy-focused stacking protocols